Related Experiment Video
Updated: Jan 30, 2026

Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
Published on: January 12, 2020
Identification of hub genes and outcome in colon cancer based on bioinformatics analysis
Wanli Yang1, Jiaojiao Ma1, Wei Zhou1
1State Key Laboratory of Cancer Biology, National Clinical Research Center for Digestive Diseases, Xijing Hospital of Digestive Diseases, Air Force Military Medical University, Xi'an, China, hongliufmmu@163.com.
Background:
Colon cancer is one of the leading malignant neoplasms worldwide. Until now, the concrete mechanisms of colonic cancerogenesis are largely unknown; identification of driven genes and pathways is, therefore, of great importance for monitoring and conquering this disease. This study aims to explore the potential biomarkers and therapeutic targets for colon cancer treatment.
Methods:
The gene expression profile of GSE44076 from Gene Expression Omnibus database, including 98 primary colon cancers and 98 normal distant colon mucosa, was deeply analyzed. GEO2R tool was used to screen the differentially expressed genes (DEGs) between colon cancer tissues and normal samples. Gene Ontology analysis and Kyoto Encyclopedia of Genes and Genomes pathway analysis were performed for screening DEGs using Database for Annotation, Visualization and Integrated Discovery database and Panther database. Moreover, Search Tool for the Retrieval of Interacting Genes, Cytoscape software, and Molecular Complex Detection plug-in were used to visualize the protein-protein interaction of these DEGs.
Results:
A total of 497 DEGs were obtained, including 129 upregulated genes mainly enriched in Hippo signaling pathway, Wnt signaling pathway, and cytokine-cytokine receptor interaction and 368 downregulated genes enriched in retinol metabolism, steroid hormone biosynthesis, drug metabolism, and chemical carcinogenesis. Using Molecular Complex Detection software, three important modules were selected from the protein-protein interaction network. Moreover, 20 hub genes with high degree of connectivity were selected, including COL1A1, CXCL5, GNG4, TIMP1, and so on. The Kaplan-Meier analysis for overall survival and correlation analysis were applied among the hub genes.
Conclusion:
Taken together, DEGs, especially the hub genes such as COL1A1, might be the driven genes in colon cancer progression. More importantly, they might be the novel biomarkers for diagnosis and guiding therapeutic strategies of colon cancer.
Insights
This study identifies key genes driving colon cancer progression. These differentially expressed genes (DEGs) and hub genes may serve as novel biomarkers for colon cancer diagnosis and treatment strategies.
Area of Science:
- Oncology
- Genomics
- Bioinformatics
Background:
- Colon cancer is a leading global malignancy with poorly understood carcinogenesis mechanisms.
- Identifying key genes and pathways is crucial for effective disease monitoring and treatment.
- This research focuses on discovering potential biomarkers and therapeutic targets for colon cancer.
Purpose of the Study:
- To explore potential biomarkers for colon cancer diagnosis.
- To identify novel therapeutic targets for colon cancer treatment.
- To elucidate the molecular mechanisms underlying colon cancer progression.
Main Methods:
- Analysis of gene expression profile GSE44076 from the Gene Expression Omnibus database.
- Screening of differentially expressed genes (DEGs) using GEO2R.
- Functional enrichment analysis (Gene Ontology, KEGG) and protein-protein interaction network analysis (STRING, Cytoscape).
Main Results:
- Identified 497 DEGs: 129 upregulated (e.g., Hippo signaling, Wnt signaling) and 368 downregulated (e.g., retinol metabolism).
- Constructed a protein-protein interaction network, identifying three key modules and 20 hub genes (e.g., COL1A1, CXCL5).
- Kaplan-Meier analysis and correlation analysis were performed on hub genes for survival insights.
Conclusions:
- Differentially expressed genes (DEGs), particularly hub genes like COL1A1, are implicated in colon cancer progression.
- These identified genes show potential as novel biomarkers for colon cancer diagnosis.
- The findings suggest these genes could guide the development of new therapeutic strategies for colon cancer.
Related Concept Videos
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Colonization of Land
Predicting Reaction Outcomes
Chromatin Position Affects Gene Expression
Topologically Associated Domains (TADs)
The 3-dimensional positioning of chromatin in the nucleus influences the...
Cancer Survival Analysis
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

